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Abstract
Background The prevalence and diagnostic value of heart
failure symptoms in elderly primary care patients with hyper-
tension is unknown.
Aim To assess the prevalence, sensitivity, specificity, positive
and negative predictive value of symptoms in association with
an abnormal echocardiogram.
Design and setting Cross-sectional screening study in five
general practices in the south-east of the Netherlands.
Method Between June 2010 and January 2013, 591 primary
care hypertension patients aged between 60 and 85 years were
included, without known heart failure and not treated by a
cardiologist. All patients underwent an echocardiogram and a
structured interview including assessment of heart failure
symptoms: shortness of breath, fatigue, oedema, cold extrem-
ities, and restless sleep.
Results and conclusion Restless sleep was reported by 25 %,
cold extremities by 23 %, fatigue by 19 %, shortness of breath
by 17 %, and oedema by 13 %. Oedema was the only symp-
tom significantly associated with an abnormal echocardio-
gram (positive predictive value was 45 %, sensitivity 20 %,
and specificity 90 %, OR 2.12; 95 % CI=1.23–3.64), apart
from higher age (OR 1.06; 95 % CI=1.03–1.09), previous
myocardial infarction (OR 3.00; 95 % CI=1.28–7.03), and a
systolic blood pressure of >160 mmHg (OR 1.62; 95 % CI=
1.08–2.41). Screening with echocardiography might be con-
sidered in patients with oedema.
Keywords Primaryhealthcare .Hypertension .Heart failure .
Echocardiography
Introduction
Hypertension is highly prevalent, with the Framingham study
showing a lifetime risk for developing hypertension of 90% in
people with a normal blood pressure at age 55 [1]. A high
blood pressure can result in coronary artery disease and
changes in ventricular function and structure [2], and is a
major risk factor for incident heart failure [3], with a 5-year
survival rate of 35 % according to previous research [4]. Early
diagnosis and treatment of heart failure are crucial for reduc-
ing heart failure related morbidity and mortality [5–7].
General practitioners (GPs) are most frequently involved in
the diagnosis of heart failure [8]. More severe hypertension in
primary care patients is associated with a higher risk of car-
diovascular events [9], and lowering blood pressure can re-
duce risk of major cardiovascular events [10]. However, less
than 50 % of patients above the age of 65 are properly
managed [11–13]. Therefore, elderly hypertension patients,
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especially those with less than optimal blood pressure, are at
high risk for heart failure.
Several important patient-reported symptoms of heart fail-
ure are oedema, dyspnoea, and fatigue [14–16]. Because most
patients with possible heart failure will present first in primary
care [16], it is important for a GP or practice nurse (PN) to
identify symptoms predictive of this condition. However,
most studies on symptoms used for assessment of heart failure
have focused on hospital populations [8] and/or on patients
who presented with dyspnoea [17, 18], or had suspected heart
failure [19]. Furthermore, the majority of studies evaluated
symptoms only in association with left ventricular systolic
dysfunction and did not take other relevant abnormalities such
as diastolic function into account [5, 8]. Left ventricular
hypertrophy (LVH), an enlarged left atrium, valvular heart
disease, and wall motion abnormalities can also be major
causes of heart failure and are related to coronary artery
disease [20–22].
Echocardiography is seen as the gold standard for the
diagnosis or confirmation of cardiac dysfunction associated
with heart failure [5] and can be used to detect cardiac abnor-
malities [2]. Although the diagnostic value of symptoms and
signs of heart failure has been the topic of debate [17], atten-
tion to symptoms can still be of relevance in patients at risk for
heart failure [5].
Until now it is unclear in elderly primary care patients with
hypertension which heart failure symptoms may be associated
with an abnormal echocardiogram. The objectives of the
current study were to examine (1) the prevalence of symptoms
which are in general related to cardiac dysfunction reflected
by an abnormal echocardiogram, (2) the sensitivity, specific-
ity, positive, and negative predictive value of symptoms of an
abnormal echocardiogram, and (3) the relation between the
symptoms and an abnormal echocardiogram, after adjustment
for several confounders.
Methods
Study design and patient population
Between June 2010 and January 2013, primary care patients
aged between 60 and 85 years, with an International
Classification of Primary Care for hypertension (K86 or
K87) as captured from their medical record, were recruited
from five general practices affiliated with the primary care
organisation PoZoB (a primary care organisation of approxi-
mately 200 GPs, located in the south of the Netherlands) for
this cross-sectional study. Exclusion criteria were: previous
diagnosis of heart failure, current treatment by a cardiologist,
history of severe psychiatric illness other than mood/anxiety
disorders and/or cognitive impairments (e.g. dementia), ter-
minal cancer, and insufficient knowledge of the Dutch
language. This study was approved by the medical ethics
committee of the Elisabeth Hospital in Tilburg, the
Netherlands.
Study procedure and data collection
Eligible patients received written information about the study
by mail and were asked to sign an informed consent form.
Patients were contacted by phone, and in case of informed
consent an appointment for an interview at their local GP
office was scheduled. This interview consisted of a structured
interview of 1 h by a trained nurse. At the end of the intake, an
appointment for the echocardiogram was scheduled which
also took place at the local GP office.
Measurements
Demographic and clinical variables
Information on demographic and clinical variables was ob-
tained from purpose-designed questions in the interview and
included gender, age, marital status, and educational level.
Furthermore, blood pressure was measured twice and the
average blood pressure was used to dichotomise systolic
blood pressure (>160 mmHg was cut-off). Height and weight
were measured in order to calculate the body mass index
(BMI). Information on clinical variables retrieved from the
patients’medical records included myocardial infarction (MI)
and peripheral arterial disease.
Assessment of symptoms
Information on heart failure symptoms was obtained during
the interview. Structured and standardised questions were
used to assess heart failure symptoms. Symptoms were
dichotomised (yes/no) and defined as: shortness of breath
during moderate exertion (e.g. walking), regularly occurring
fatigue, oedema of the legs, ankles and/or feet, having cold
extremities, and restless sleep, during the past 4 weeks.
Assessment of the echocardiogram
The echocardiogram was performed and evaluated by an
experienced echocardiographer of the local primary care lab-
oratory located in Eindhoven, the Netherlands. All the echo-
cardiograms were reviewed by a cardiologist specialised in
echocardiography, who indicated if the echocardiogram was
abnormal according to a protocol suitable for primary care,
based on current guidelines [23, 24]. The definition of an
abnormal echocardiogram is shown in Table 1.
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Statistical analyses
Statistical analyses were performed using the IBM Statistical
Package for the Social Sciences version 18.0. Differences in
baseline characteristics were compared between normal and
abnormal echocardiograms and assessed with Chi-square tests
or Student’s/Welch’s T-tests when appropriate. For each
symptom and clinical variable, the sensitivity, specificity,
positive predictive value, and negative predictive value with
95 % confidence intervals were calculated.
Adjusted odds ratios were calculated using multiple logis-
tic regression, with an abnormal echocardiogram (taking all
cardiac abnormalities together) as dependent variable. A pos-
sible relation between symptoms and an abnormal echocar-
diogram were adjusted for age, gender, education, having a
partner, previous MI, peripheral arterial disease, and elevated
systolic blood pressure of >160 mmHg.
Results
Patient recruitment
From 6 different GP practices, 913 eligible patients with
hypertension were approached and 619 (68%) patients agreed
to participate. Of these participants, 2 were excluded post-hoc
because they met the exclusion criterion of being treated by a
cardiologist, 5 were excluded post-hoc because the echocar-
diogram was not of sufficient quality and 16 patients did not
have an echocardiogram, of which 3 were admitted to the
hospital, 1 died, and 12 did not show up. Patients with con-
genital disease and/or hypertrophic cardiomyopathy were ex-
cluded from analyses (n=5), leaving a total of 591 (65 %)
patients for analysis.
Baseline characteristics
Tables 2 shows the baseline characteristics. The mean age of
the study patients was 70±6.5 years and 44 % were male (n=
262). Patients with an abnormal echocardiogram were signif-
icantly older, less often had a partner, were more likely to have
had a previousMI, and had a higher systolic blood pressure as
compared with the patients with a normal echocardiogram.
Abnormalities on the echocardiogram were present in 30 % of
the study sample (Table 1).
Heart failure symptoms and abnormal echocardiogram
Restless sleep was the most prevalent symptom (25 %, n=
149). The most sensitive was shortness of breath with a
sensitivity of 32 %. The most specific symptom was oedema
of the ankles, feet, or legs, with a high specificity of 90 %.
Oedema also had the highest positive predictive value (45 %)
and negative predictive value (73 %) for an abnormal echo-
cardiogram (Table 3).
In adjusted analysis (Table 4), oedema was significantly
and independently related to an abnormal echocardiogram
adjusted for age, sex, having a partner, the co-existence of
type 2 diabetes or peripheral arterial disease, systolic blood
pressure >160 mmHg. The other symptoms were not signifi-
cantly associated with an abnormal echocardiogram in adjust-
ed analysis.
Discussion
The current study shows that regular restless sleep was report-
ed by 25%, having cold extremities by 23%, fatigue by 19%,
shortness of breath by 17 %, and oedema of legs, ankles and/
or feet by 13 %. An abnormal echocardiogram was present in
30 %. Oedema is an important symptom of cardiac dysfunc-
tion as reflected by an abnormal echocardiogram. In adjusted
analysis, oedema was the only symptom that was significantly
associated with abnormal echocardiogram apart from higher
age, previous MI, and a systolic blood pressure of
>160 mmHg. The symptoms shortness of breath, fatigue,
having cold extremities, and having restless sleep were of
limited value in predicting an abnormal echocardiogram.
Strengths and limitations
This study is among the first to evaluate the value of heart
failure symptoms in the diagnosis of cardiac dysfunction in
Table 1 Prevalence of abnormal echocardiogram parameters in 591
elderly primary care hypertension patients
Total
(n=591)
Abnormalities on the echocardiogram
LAVI >29 ml/m2 60 (10 %)
LVEF <55 % 51 (9 %)
Valvular abnormalities 48 (8 %)
LVH septal and posterior wall thickness of ≥13
mm (moderate or severe)
36 (6 %)
Diastolic dysfunction (E/A ratio of <1 and DTs
of >200 ms, and presence of LVH in case of
grade I diastolic dysfunction)
35 (6 %)
Wall motion abnormalities (hypokinesia, akinesia
and dyskinesia)
26 (4 %)
RVH; subcostal wall thickness of ≥6 mm (mild,
moderate or severe)
15 (3 %)
Total ≥1 abnormality 175 (30 %)
Total ≥2 abnormality 74 (13 %)
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LAVI left atrial volume index, LVEF left ventricular ejection fraction, LVH
left ventricular hypertrophy, RVH right ventricular hypertrophy, DT de-
celeration time
unselected elderly primary care patients with hypertension.
Since hypertension is one of the most important risk factors
for incident heart failure [3] and elderly hypertension patients
represent a large proportion of patients in whom cardiovascu-
lar riskmanagement is crucial, the results of this study are very
relevant. By using echocardiography, we studied the associa-
tion between symptoms and cardiac abnormalities and heart
failure, including left ventricular dysfunction, diastolic
dysfunction, LVH, and valvular dysfunction. A majority of
research evaluated the association of symptoms and left ven-
tricular systolic dysfunction only, and did not take other
cardiac dysfunctions into account [8].
Some methodological issues need consideration. First, the
cross-sectional design of the study does not allow for evalu-
ation of the course of symptoms in relation to cardiac dys-
function. Second, the study population was primarily
Table 2 Baseline characteristics of 591 elderly primary care hypertension patients
Characteristic Total, N=591 Normal
echocardiogram, N=416
Abnormal
echocardiogram, N=175
P-value
Demographics
Male 262 (44 %) 180 (43 %) 82 (47 %) 0.423
Female 329 (56 %) 236 (57 %) 93 (53 %) 0.423
Age, mean (SD) 69.9 (6.5) 69.1 (6.1) 72.0 (7.0) <0.001
Low education 76 (13 %) 55 (13 %) 21 (12 %) 0.686
Having a partner 443 (75 %) 324 (78 %) 119 (68 %) 0.011
Lifestyle
Current smoker 77 (13 %) 61 (15 %) 16 (9 %) 0.069
Regular alcohol use (≥2 glasses per day) 188 (32 %) 133 (32 %) 55 (31 %) 0.897
Clinical characteristics and risk factors
Previous myocardial infarction 27 (5 %) 11 (3 %) 16 (9 %) 0.001
Peripheral artery disease 23 (4 %) 12 (3 %) 11 (6 %) 0.051
TIA/stroke 52 (9 %) 33 (8 %) 19 (11 %) 0.252
Diabetes type 2 67 (11 %) 45 (11 %) 22 (13 %) 0.539
GFR <60 (n=575) 102 (18 %) 72 (17 %) 30 (17 %) 0.962
Mean SBP (mmHg), mean (SD) (N=587) 150 (19.6) 147 (18.0) 155 (22.2) <0.001
SBP >160 mmHg (N=587) 168 (29 %) 104 (25 %) 64 (37 %) 0.005
Mean DBP (mmHg), mean (SD) (N=587) 82.2 (10.5) 82.0 (10.3) 82.8 (10.9) 0.351
DBP >90 mmHg (N=587) 120 (20 %) 83 (20 %) 37 (21 %) 0.784
BMI (kg/m2), mean (SD) 28.0 (4.5) 28.1 (4.6) 27.7 (4.1) 0.356
Antihypertensive medication
Diuretics 308 (52 %) 220 (53 %) 88 (50 %) 0.564
Angiotensin receptor blockers 178 (30 %) 137 (33 %) 41 (23 %) 0.021
Angiotensin II receptor antagonists 229 (39 %) 160 (39 %) 69 (39 %) 0.826
Beta-blockers 197 (33 %) 118 (28 %) 79 (45 %) <0.001
Calcium antagonists 111 (19 %) 66 (16 %) 45 (26 %) 0.005
TIA transient ischaemic attack, BMI body mass index, GFR glomerular filtration rate, SBP systolic blood pressure, DBP diastolic blood
Table 3 Sensitivity, specificity, positive predictive value, negative predictive value of symptoms associated with an abnormal echocardiogram
(N=175/591, 30 %)
N (%) Sensitivity 95 % CI Specificity 95 % CI PPV 95 % CI NPV 95 % CI
Shortness of breath 102 (17 %) 32.3 % 14.3–20.6 % 71.0 % 66.6–74.9 % 29.6 % 26.0–33.5 % 70.4 % 66.5–74.0 %
Fatigue 110 (19 %) 20.6 % 15.0–27.5 % 82.2 % 78.1–85.7 % 32.7 % 24.3–42.4 % 71.1 % 66.8–75.1 %
Oedema of ankles, feet, legs 78 (13 %) 20.0 % 14.5–26.9 % 89.7 % 86.2–92.3 % 44.9 % 33.7–56.5 % 72.7 % 68.6–76.4 %
Cold extremities 137 (23 %) 28.0 % 21.6–35.4 % 78.8 % 74.5–82.6 % 35.7 % 27.9–44.4 % 72.2 % 67.8–76.3 %
Restless sleep 149 (25 %) 22.9 % 17.0–29.9 % 73.8 % 69.2–77.9 % 26.8 % 20.0–34.8 % 69.5 % 64.9–73.7 %
NPV negative predictive value, PPV positive predictive value
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Caucasian (99 %) limiting generalisability to other popula-
tions with more ethnic diversity. Another limitation is that we
do not have detailed demographic information of the non-
responders. However, the response rate in the current study
was almost 70 %. Moreover, the current design was not used
to assess prevalence figures but rather to evaluate whether
signs and symptoms could be associated with echocardiogram
outcome.
Comparison with existing literature
Previous research showed that the most common symptoms
associated with heart failure are oedema, dyspnoea, and fa-
tigue [14, 15]. However, most previous studies looking at the
value of symptoms in the diagnosis of heart failure used
selected samples of patients who were referred because of
symptoms [25]. For example, patients in the study by Davie
et al., in which the symptom oedema had no predictive value
with low sensitivity and specificity, were referred for diagno-
sis of heart failure and the largemajority were referred because
of symptoms (dyspnoea) [19]. In another primary care study
in patients with suspected heart failure similar findings were
reported; oedema had limited value in the diagnosis of heart
failure, and as in the current study no other symptoms were
associated with heart failure diagnosis [17]. However, patients
who visited for a specialised hypertension consultation were
excluded, limiting the possibility to generalise the results to
hypertension patients. Furthermore, in early stages of heart
failure, milder symptoms do occur, which are generally insen-
sitive in the diagnosis of heart failure [6]. Nevertheless, a
diagnostic tool for heart failure in primary care was devel-
oped, based on a systematic review. According to this re-
search, patients who present with symptoms of heart failure
are most at risk when there is a history of MI, basal crepita-
tions are present, and the patient is male with ankle oedema.
The inclusion of oedema in this tool is more in line with our
findings; however, this tool was developed for populations of
patients with already suspected heart failure with presentation
of symptoms [26], and therefore this tool is most likely not
suitable for unselected elderly primary care patients with
hypertension patients.
Although breathlessness is the most commonly reported
symptom in established heart failure in primary care [16], our
findings showed that oedema, and not shortness of breath, was
significantly and independently associated with cardiac dys-
function as reflected by an abnormal echocardiogram, together
with previous MI, higher age, and elevated systolic blood
pressure. However, oedema had a low sensitivity making it less
useful for ruling out cardiac dysfunction in elderly hypertension
patients. The low sensitivity of all symptoms in our study can
possibly be explained by the mild severity of cardiac dysfunc-
tion, with the majority of patients not reporting any symptoms.
Implications
In themajority of cases theGP is involved in the initial diagnosis
of heart failure [16]. Therefore, attention to cardiac dysfunction
predictive of chronic heart failure is important, especially in
primary care populations at increased risk. The results of our
study show that oedema of the lower limbs is significantly
associated with cardiac dysfunction on an echocardiogram in
elderly hypertension patients, it has modest positive predictive
value, but adequate specificity. Although the value of symptoms
is limited in the diagnosis of heart failure [17], oedema of the
lower limbs could be of diagnostic value. The presence of
oedema in elderly hypertension patients could alert the GP to
initiate further assessment of cardiac function by means of
echocardiography. To conclude, it would be recommended
Table 4 Correlates of abnormal echocardiogram in elderly primary care
hypertension patients (adjusted analysis; N=587)
Odds ratio (95 % CI) P-value
Unadjusted analysis
Demographics
Female gender 0.87 (0.61–1.23) 0.423
Age 1.07 (1.04–1.10) <0.001
Having a partner 0.60 (0.41–0.89) 0.012
Clinical history
Previous myocardial infarction 3.71 (1.68–8.16) 0.001
Peripheral arterial disease 2.26 (0.98–5.22) 0.057
SBP >160 mmHg 1.70 (1.16–2.49) 0.006
Symptoms
Shortness of breath 1.17 (0.74–1.85) 0.505
Fatigue 1.20 (0.77–1.87) 0.428
Oedema of lower extremities 2.17 (1.33–3.53) 0.002
Cold extremities 1.45 (0.97–2.17) 0.073
Restless sleep 0.84 (0.55–1.26) 0.393
Adjusted analysis
Demographics
Female gender 0.83 (0.56–1.25) 0.378
Age 1.06 (1.03–1.09) <0.001
Having a partner 0.71 (0.46–1.11) 0.135
Clinical history
Previous myocardial infarction 3.00(1.28–7.03) 0.011
Peripheral arterial disease 1.44 (0.70–4.37) 0.230
SBP >160 mmHg 1.62 (1.08–2.41) 0.019
Symptoms
Shortness of breath 0.90 (0.53–1.53) 0.702
Fatigue 0.92 (0.54–1.56) 0.763
Oedema of lower extremities 2.12 (1.23–3.64) 0.007
Cold extremities 1.30 (0.84–2.01) 0.240
Restless sleep 0.95 (0.61–1.50) 0.836
SBP systolic blood pressure, DBP diastolic blood
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for GPs to check for oedema and consider an echocar-
diogram for further diagnosis of cardiac dysfunction,
especially in elderly hypertension patients with a poorly con-
trolled systolic blood pressure and/or a previous MI.
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